Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice
Maxwell P. Lee, … , Robert J. Coffey, Andrew P. Feinberg
Maxwell P. Lee, … , Robert J. Coffey, Andrew P. Feinberg
Published December 15, 2000
Citation Information: J Clin Invest. 2000;106(12):1447-1455. https://doi.org/10.1172/JCI10897.
View: Text | PDF
Article

Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice

  • Text
  • PDF
Abstract

The KvLQT1 gene encodes a voltage-gated potassium channel. Mutations in KvLQT1 underlie the dominantly transmitted Ward-Romano long QT syndrome, which causes cardiac arrhythmia, and the recessively transmitted Jervell and Lange-Nielsen syndrome, which causes both cardiac arrhythmia and congenital deafness. KvLQT1 is also disrupted by balanced germline chromosomal rearrangements in patients with Beckwith-Wiedemann syndrome (BWS), which causes prenatal overgrowth and cancer. Because of the diverse human disorders and organ systems affected by this gene, we developed an animal model by inactivating the murine Kvlqt1. No electrocardiographic abnormalities were observed. However, homozygous mice exhibited complete deafness, as well as circular movement and repetitive falling, suggesting imbalance. Histochemical study revealed severe anatomic disruption of the cochlear and vestibular end organs, suggesting that Kvlqt1 is essential for normal development of the inner ear. Surprisingly, homozygous mice also displayed threefold enlargement by weight of the stomach resulting from mucous neck cell hyperplasia. Finally, there were no features of BWS, suggesting that Kvlqt1 is not responsible for BWS.

Authors

Maxwell P. Lee, Jason D. Ravenel, Ren-Ju Hu, Lawrence R. Lustig, Gordon Tomaselli, Ronald D. Berger, Sheri A. Brandenburg, Tracy J. Litzi, Tracie E. Bunton, Charles Limb, Howard Francis, Melissa Gorelikow, Hua Gu, Kay Washington, Pedram Argani, James R. Goldenring, Robert J. Coffey, Andrew P. Feinberg

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Mutational inactivation of the mouse Kvlqt1 gene. (a) Mouse Kvlqt1 genom...
Mutational inactivation of the mouse Kvlqt1 gene. (a) Mouse Kvlqt1 genomic locus and knockout construct. Top: restriction map of exons 1 and 2; middle: 6-kb EcoRV-EcoRI fragment subcloned into pBluescript. The open box denotes the insertion of the neo gene in exon 1. The neo cassette was inserted after A345 as marked by the arrow in the following sequence: CCACTATTGA↓GCAGTATGCC. The nucleotide sequences are based on U70068. The KvLQT1 is translated from the nucleotide 104. The exon 1 is shared by all isoforms, so targeting at exon 1 inactivates all KvLQT1 isoforms. The detailed description of isoforms and their organization can be found in ref. 5. The dashed lines mark the targeted region for homologous recombination. Bottom: restriction map of the Kvlqt1 locus after recombination. A diagnostic Pvu II site generates a mutant-specific 3.9-kb fragment using the probe indicated, in contrast to a 4.2-kb Pvu II fragment in the wild-type mouse locus. (b) Genotyping of transgenic mice. Genomic DNA was digested with Pvu II and hybridized with the probe shown in a. The +/+ indicates wild-type as demonstrated by a single 4.2-kb Pvu II fragment, +/– indicates heterozygous mice as demonstrated by the presence of both 4.2- and 3.9-kb fragments, and –/– indicates homozygous mutant as demonstrated by a single 3.9-kb mutant Pvu II fragment. This is also consistent with typing by PCR (data not shown) and phenotype. (c) Presence or absence of KvLQT1 expression in wild-type and mutant mice, as measured by RT-PCR using primers spanning an intron-exon boundary. The forward primer, mLQT111 (GTGTTTCGTGTACCACTTCACCGTCTT), in exon 1a and exon 1 (across the junction) is upstream to the neo insertion site, and reverse primer, mLQT211 (TACCATTGGCTACGGGGATAAGGTACC) in exon 6 is downstream to the neo insertion site. The presence of a 1.6-kb insertion in homozygous mutant mice prevents the efficient amplification in RT-PCR reaction.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts